Deiodinase 1 (DIO1) Attenuates Renal Ischemia-Reperfusion Injury by Suppressing the NLRP3 Inflammasome
Renal ischemia-reperfusion injury (RIRI) is a leading cause of acute kidney injury (AKI), and inflammation driven by excessive NLRP3 inflammasome activation is a key pathological event in its progression. Deiodinase 1 (DIO1), a selenoprotein highly expressed in the kidney, has an undefined role in RIRI. This study aimed to investigate the protective effect of DIO1 against RIRI and the underlying mechanisms. A mouse RIRI model was established by bilateral renal artery clamping for 30 min, and mice were randomized to sham, IR, DIO1 activation (T3 pretreatment), and NLRP3 inhibitor (INF39) groups. Renal function, histopathology, and the expression of DIO1, NLRP3, and IL-1β were assessed 24 h after reperfusion. In vitro, DIO1-overexpressing HK-2 cells subjected to hypoxia-reoxygenation with or without nigericin (NSS) were examined by Western blot. DIO1 expression was markedly downregulated in RIRI kidneys; T3-mediated DIO1 activation significantly improved renal function and histopathology and reduced NLRP3 and IL-1β expression, comparably to INF39. In vitro, DIO1 overexpression significantly downregulated the expression of NLRP3, Caspase-1, GSDMD, IL-1β, IL-18, and p-NF-κB p65. These findings indicate that DIO1 protects against RIRI, likely by suppressing NF-κB/NLRP3 signaling activation and inflammatory cytokine release, and may represent a potential therapeutic target for RIRI.
Authors
- Shuxiong Xu (ORCID: https://orcid.org/0000-0002-3601-2711)
- Guofeng Shu
- Yikun Wu
- Yu Xiao
Institutions
- Guizhou Provincial People's Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-20
- DOI
- https://doi.org/10.21203/rs.3.rs-11690616/v1
- Primary Topic
- Acute Kidney Injury Research
- Type
- preprint